Xiaowei Luo

Dr. Xiaowei Luo

Guangxi University of Chinese Medicine, Nanning, Guangxi, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2018 in Journal of Natural Products
Verified
Journal Article
Closed access
XLXiaowei Luo
Xiaowei Luo
XLXiuping Lin
Xiuping Lin
Huaming TaoHuaming Tao
Huaming Tao
JWJunfeng Wang
Junfeng Wang
JLJiayi Li
Jiayi Li
Yonghong LiuYonghong Liu
Yonghong Liu

10 March 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
CCChunmei Chen
Chunmei Chen
HTHuaming Tao
Huaming Tao
WCWeihao Chen
Weihao Chen
BYBin Yang
Bin Yang
Xuefeng ZhouXuefeng Zhou
Xuefeng Zhou
Yonghong LiuYonghong Liu
Yonghong Liu
Azaphilones have continuously aroused considerable attention owing to their structural diversity and significant biological activities recently. This review attempts to give a comprehensive summary of recent progress on the isolation, identification, and biological activity, along with synthetic and biosynthetic studies of azaphilones reported from October 2012 to December 2019. Herein, a total of 252 compounds predominantly originated from 32 genera of fungi, such as Penicillium (20%) and Talaromyces (11%), were included in this research with citations of 105 references. Among these azaphilones, approximately half of them were found with various biological activities, of which over 40% displayed cytotoxic/anti-tumor effects. This review would shed light on the future development and research of azaphilones.

12 July 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Xuefeng ZhouXuefeng Zhou
Xuefeng Zhou
ZLZhi Liang
Zhi Liang
KLKunlong Li
Kunlong Li
WFWei Fang
Wei Fang
TYTian Yuanxin
Tian Yuanxin
LTLan Tang
Lan Tang

3 January 2018 in Journal of Natural Products
Verified
Journal Article
Closed access
YTYanhui Tan
Yanhui Tan
Bin YangBin Yang
Bin Yang
XLXiuping Lin
Xiuping Lin
XLXiaowei Luo
Xiaowei Luo
XPXiaoyan Pang
Xiaoyan Pang
Xuefeng ZhouXuefeng Zhou
Xuefeng Zhou

13 September 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XLXiaowei Luo
Xiaowei Luo
GCGuodi Cai
Guodi Cai
YGYinfeng Guo
Yinfeng Guo
CGChenghai Gao
Chenghai Gao
WHWeifeng Huang
Weifeng Huang
Yonghong LiuYonghong Liu
Yonghong Liu

12 July 2018 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
XLXiaowei Luo
Xiaowei Luo
JYJie Yang
Jie Yang
FCFeimin Chen
Feimin Chen
XLXiuping Lin
Xiuping Lin
CCChunmei Chen
Chunmei Chen
Yonghong LiuYonghong Liu
Yonghong Liu
Influenza A virus (IAV) is a severe worldwide threat to public health and economic development due to its high morbidity and mortality. Marine-derived fungi have been evidenced as a prolific source for the discovery of pharmacologically-active lead compounds. During the course of our search for novel bioactive substances from marine microorganisms, six new polyketides, including two octaketides (1–2), one chromone derivative (13), two highly substituted phthalides (17–18), and one α-pyrone derivative (21) along with 22 known congeners were isolated from a mangrove-associated fungus Diaporthe sp. SCSIO 41011. Their structures were determined by spectroscopic analysis and by comparison with literature data. And the absolute configurations were established according to the specific rotation or electron circular dichroism method. Antiviral evaluation results revealed that compounds 14, 15, 26, and 5-chloroisorotiorin displayed significant anti-IAV activities against three influenza A virus subtypes, including A/Puerto Rico/8/34 H274Y (H1N1), A/FM-1/1/47 (H1N1), and A/Aichi/2/68 (H3N2), with IC50 values in the range of 2.52–39.97 μM. The preliminary structure-activity relationships (SARs) are also discussed. These findings expand the chemical and bioactive diversity of polyketides derived from the genus Diaporthe, and also provide a basis for further development and utilization of chromone, xanthone, and chloroazaphilone derivatives as source of potential anti-viral chemotherapy agents.